Adiponectin, driver or passenger on the road to insulin sensitivity?

Risheng Ye, Philipp E. Scherer

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Almost 20 years have passed since the first laboratory evidence emerged that an abundant message encoding a protein with homology to the C1q superfamily is highly specifically expressed in adipocytes. At this stage, we refer to this protein as adiponectin. Despite more than 10,000 reports in the literature since its initial description, we seem to have written only the first chapter in the textbook on adiponectin physiology. With every new aspect we learn about adiponectin, a host of new questions arise with respect to the underlying molecular mechanisms.Here, we aim to summarize recent findings in the field and bring the rodent studies that suggest a causal relationship between adiponectin levels in plasma and systemic insulin sensitivity in perspective with the currently available data on the clinical side.

Original languageEnglish (US)
Pages (from-to)133-141
Number of pages9
JournalMolecular Metabolism
Volume2
Issue number3
DOIs
StatePublished - Aug 2013

Fingerprint

Adiponectin
Insulin Resistance
Textbooks
Adipocytes
Rodentia
Proteins

Keywords

  • AdipoR
  • AMPK
  • Ceramide
  • Human
  • Insulin sensitivity
  • Mouse
  • Oligomeric complexes

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Adiponectin, driver or passenger on the road to insulin sensitivity? / Ye, Risheng; Scherer, Philipp E.

In: Molecular Metabolism, Vol. 2, No. 3, 08.2013, p. 133-141.

Research output: Contribution to journalArticle

@article{24e5c584c41a4b4aae518f2dd20a72d2,
title = "Adiponectin, driver or passenger on the road to insulin sensitivity?",
abstract = "Almost 20 years have passed since the first laboratory evidence emerged that an abundant message encoding a protein with homology to the C1q superfamily is highly specifically expressed in adipocytes. At this stage, we refer to this protein as adiponectin. Despite more than 10,000 reports in the literature since its initial description, we seem to have written only the first chapter in the textbook on adiponectin physiology. With every new aspect we learn about adiponectin, a host of new questions arise with respect to the underlying molecular mechanisms.Here, we aim to summarize recent findings in the field and bring the rodent studies that suggest a causal relationship between adiponectin levels in plasma and systemic insulin sensitivity in perspective with the currently available data on the clinical side.",
keywords = "AdipoR, AMPK, Ceramide, Human, Insulin sensitivity, Mouse, Oligomeric complexes",
author = "Risheng Ye and Scherer, {Philipp E.}",
year = "2013",
month = "8",
doi = "10.1016/j.molmet.2013.04.001",
language = "English (US)",
volume = "2",
pages = "133--141",
journal = "Molecular Metabolism",
issn = "2212-8778",
publisher = "Elsevier GmbH",
number = "3",

}

TY - JOUR

T1 - Adiponectin, driver or passenger on the road to insulin sensitivity?

AU - Ye, Risheng

AU - Scherer, Philipp E.

PY - 2013/8

Y1 - 2013/8

N2 - Almost 20 years have passed since the first laboratory evidence emerged that an abundant message encoding a protein with homology to the C1q superfamily is highly specifically expressed in adipocytes. At this stage, we refer to this protein as adiponectin. Despite more than 10,000 reports in the literature since its initial description, we seem to have written only the first chapter in the textbook on adiponectin physiology. With every new aspect we learn about adiponectin, a host of new questions arise with respect to the underlying molecular mechanisms.Here, we aim to summarize recent findings in the field and bring the rodent studies that suggest a causal relationship between adiponectin levels in plasma and systemic insulin sensitivity in perspective with the currently available data on the clinical side.

AB - Almost 20 years have passed since the first laboratory evidence emerged that an abundant message encoding a protein with homology to the C1q superfamily is highly specifically expressed in adipocytes. At this stage, we refer to this protein as adiponectin. Despite more than 10,000 reports in the literature since its initial description, we seem to have written only the first chapter in the textbook on adiponectin physiology. With every new aspect we learn about adiponectin, a host of new questions arise with respect to the underlying molecular mechanisms.Here, we aim to summarize recent findings in the field and bring the rodent studies that suggest a causal relationship between adiponectin levels in plasma and systemic insulin sensitivity in perspective with the currently available data on the clinical side.

KW - AdipoR

KW - AMPK

KW - Ceramide

KW - Human

KW - Insulin sensitivity

KW - Mouse

KW - Oligomeric complexes

UR - http://www.scopus.com/inward/record.url?scp=84883234646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883234646&partnerID=8YFLogxK

U2 - 10.1016/j.molmet.2013.04.001

DO - 10.1016/j.molmet.2013.04.001

M3 - Article

VL - 2

SP - 133

EP - 141

JO - Molecular Metabolism

JF - Molecular Metabolism

SN - 2212-8778

IS - 3

ER -